Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT06887296

NCT06887296
Completed Not Applicable

Who may be able to join

"Who might be able to join this trial:

For the PCOS group:

  • You must be an adult
  • You must have been medically diagnosed with polycystic ovarian syndrome (PCOS)
  • You must have no objection to taking part in the study

For the control group (people without PCOS):

  • You must be an adult
  • You must not have polycystic ovarian syndrome (PCOS)
  • You must have no objection to taking part in the study

Who may not be able to join:

  • People who are under a court-ordered legal protection measure, such as guardianship or similar arrangements
  • People who do not understand or speak French

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
University Hospital, Toulouse
Registry
clinicaltrials_gov
Start date
30 June 2025
Est. completion
24 October 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Evaluation of Sexual Function and Distress in Women with Polycystic Ovary Syndrome Using BISF-W Scores; Evaluation of Sexual Function and Distress in Women with Polycystic Ovary Syndrome Using FSDS-R Scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov